$CPSS
Consumer Portfolio Services Inc Stock $cpss

$cpss Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000168316824003234 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$90.38M	$91.74M
YoY Change	6.51%	10.4%
Cost Of Revenue	$46.71M	$41.97M
YoY Change	30.82%	28.11%
Gross Profit	$43.67M	$44.78M
YoY Change	-11.15%	-11.05%
Gross Profit Margin	48.32%	48.81%
Selling, General & Admin	$36.99M	$18.62M
YoY Change	12.31%	-44.29%
% of Gross Profit	84.69%	41.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$221.0K	$215.0K
YoY Change	4.74%	-6.93%
% of Gross Profit	0.51%	0.48%
Operating Expenses	$42.50M	$85.19M
YoY Change	39.12%	166.96%
Operating Profit	$1.172M	-$40.41M
YoY Change	-93.7%	-319.26%
Interest Expense	$5.500M	$41.97M
YoY Change
% of Operating Profit	469.28%
Other Income/Expense, Net
YoY Change
Pretax Income	$6.672M	$6.557M
YoY Change	-64.14%	-64.42%
Income Tax	$2.000M	$1.967M
% Of Pretax Income	29.98%	30.0%
Net Earnings	$4.672M	$4.590M
YoY Change	-66.52%	-66.79%
Net Earnings / Revenue	5.17%	5.0%
Basic Earnings Per Share	$0.22	$0.22
Diluted Earnings Per Share	$0.19	$0.19
COMMON SHARES
Basic Shares Outstanding	21.02M shares	21.13M shares
Diluted Shares Outstanding	24.26M shares	24.60M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.752M	$13.25M
YoY Change	37.72%	30.05%
Cash & Equivalents	$9.752M	$13.25M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$12.03M	$16.89M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$21.78M	$30.14M
YoY Change	-59.24%	-53.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.192M	$1.268M
YoY Change	-7.17%	-13.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$259.3M	$42.55M
YoY Change	66.81%	-74.77%
Total Long-Term Assets	$3.265B	$2.976B
YoY Change	16.58%	7.39%
TOTAL ASSETS
Total Short-Term Assets	$21.78M	$30.14M
Total Long-Term Assets	$3.265B	$2.976B
Total Assets	$3.287B	$3.007B
YoY Change	15.16%	5.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$66.39M	$55.34M
YoY Change	15.7%	-7.5%
Accrued Expenses	$23.23M	$23.70M
YoY Change	340.71%	359.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$66.39M	$79.04M
YoY Change	15.7%	32.12%
LONG-TERM LIABILITIES
Long-Term Debt	$2.940B	$2.648B
YoY Change	15.68%	4.51%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.940B	$2.648B
YoY Change	15.68%	4.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.39M	$79.04M
Total Long-Term Liabilities	$2.940B	$2.648B
Total Liabilities	$3.006B	$2.727B
YoY Change	15.68%	5.15%
SHAREHOLDERS EQUITY
Retained Earnings	$257.1M	$252.4M
YoY Change	11.65%	16.69%
Common Stock	$25.06M	$28.52M
YoY Change	-10.29%	-3.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$280.3M	$279.1M
YoY Change
Total Liabilities & Shareholders Equity	$3.287B	$3.007B
YoY Change	15.16%	5.99%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$4.672M	$4.590M
YoY Change	-66.52%	-66.79%
Depreciation, Depletion And Amortization	$221.0K	$215.0K
YoY Change	4.74%	-6.93%
Cash From Operating Activities	$43.29M	$52.71M
YoY Change	-22.03%	-19.09%
INVESTING ACTIVITIES
Capital Expenditures	$145.0K	$111.0K
YoY Change	353.13%	226.47%
Acquisitions
YoY Change
Other Investing Activities	-$209.0M	-$108.5M
YoY Change	190.87%	-10.41%
Cash From Investing Activities	-$209.2M	-$108.6M
YoY Change	190.94%	-10.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	281.5M	$81.45M
YoY Change	11434.21%	30.71%
NET CHANGE
Cash From Operating Activities	43.29M	$52.71M
Cash From Investing Activities	-209.2M	-$108.6M
Cash From Financing Activities	281.5M	$81.45M
Net Change In Cash	115.7M	$25.52M
YoY Change	-929.73%	305.53%
FREE CASH FLOW
Cash From Operating Activities	$43.29M	$52.71M
Capital Expenditures	$145.0K	$111.0K
Free Cash Flow	$43.15M	$52.59M
YoY Change	-22.24%	-19.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
CY2023Q1	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
CY2024Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	84288000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	80062000	usd
CY2024Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-5000000	usd
CY2023Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-0	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	2456000	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	3038000	usd
CY2024Q1	us-gaap	Revenues Revenues	91744000	usd
CY2023Q1	us-gaap	Revenues Revenues	83100000	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	24416000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	22033000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13753000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11396000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	41968000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	32759000	usd
CY2024Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	1635000	usd
CY2023Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	9000000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4870000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5724000	usd
CY2024Q1	us-gaap	Occupancy Net OccupancyNet	1600000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	1526000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	215000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	231000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	85187000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	64669000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6557000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18431000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1967000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4608000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	4590000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13823000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21143000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20418000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24602000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25392000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	4590000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13823000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4590000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-13823000	usd
CY2024Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	54247000	usd
CY2023Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	47472000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	215000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	231000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-672000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2403000	usd
CY2024Q1	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	-5000000	usd
CY2023Q1	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	0	usd
CY2024Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	1635000	usd
CY2023Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	9000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	832000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	912000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-251000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-385000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16702000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4511000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16579000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4404000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52705000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	65141000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-9428000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-24746000	usd
CY2024Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	328893000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	352598000	usd
CY2024Q1	cpss	Payments Received On Finance Receivables At Fair Value PaymentsReceivedOnFinanceReceivablesAtFairValue	-210935000	usd
CY2023Q1	cpss	Payments Received On Finance Receivables At Fair Value PaymentsReceivedOnFinanceReceivablesAtFairValue	-206626000	usd
CY2024Q1	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-9000	usd
CY2023Q1	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-101000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	111000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108632000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121159000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	280924000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	324768000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	5489000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	537000	usd
CY2023Q1	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1820000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	17176000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-7000	usd
CY2024Q1	cpss	Repayment Of Residual Interest Financing Debt RepaymentOfResidualInterestFinancingDebt	-50000000	usd
CY2023Q1	cpss	Repayment Of Residual Interest Financing Debt RepaymentOfResidualInterestFinancingDebt	-0	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	268710000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	258224000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1899000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2072000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1697000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7293000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	705000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6960000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81451000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62312000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25524000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6294000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125431000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162789000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150955000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169083000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	42145000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	29658000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	usd
CY2024Q1	cpss	Rightofuse Asset Net RightofuseAssetNet	-23267000	usd
CY2023Q1	cpss	Rightofuse Asset Net RightofuseAssetNet	-3013000	usd
CY2024Q1	cpss	Lease Liability LeaseLiability	23782000	usd
CY2023Q1	cpss	Lease Liability LeaseLiability	3313000	usd
CY2024Q1	cpss	Deferred Office Rent DeferredOfficeRent	-515000	usd
CY2023Q1	cpss	Deferred Office Rent DeferredOfficeRent	-300000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	274668000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	228389000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	279098000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	242791000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zRtAIGbT0Z21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_864_zT1SP7CTRagd">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, as well as the reported amounts of income and expenses during the reported periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p>
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	2456000	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	3038000	usd
CY2024Q1	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	51093000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	29575000	usd
CY2024Q1	cpss	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	27902000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	26651000	usd
CY2024Q1	cpss	Operating Lease Right Of Use Asset1 OperatingLeaseRightOfUseAsset1	23191000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset1 OperatingLeaseRightOfUseAsset1	2924000	usd
CY2024Q1	cpss	Operating Lease Liability1 OperatingLeaseLiability1	23702000	usd
CY2023Q4	cpss	Operating Lease Liability1 OperatingLeaseLiability1	3220000	usd
CY2024Q1	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3474000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3474000	usd
CY2024Q1	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	3398000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	3385000	usd
CY2024Q1	cpss	Finance Lease Right Of Use Asset1 FinanceLeaseRightOfUseAsset1	76000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset1 FinanceLeaseRightOfUseAsset1	89000	usd
CY2024Q1	cpss	Finance Lease Liability1 FinanceLeaseLiability1	80000	usd
CY2023Q4	cpss	Finance Lease Liability1 FinanceLeaseLiability1	93000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1374000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1360000	usd
CY2024Q1	cpss	Finance Lease Cost FinanceLeaseCost	14000	usd
CY2023Q1	cpss	Finance Lease Cost FinanceLeaseCost	101000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	1388000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1461000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1374000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1360000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99000	usd
CY2024Q1	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	1000	usd
CY2023Q1	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	2000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	832000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	912000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5100000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7945000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6070000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6062000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23900000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20600000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	716000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3800000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2684000	shares
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zBGCY1aic1db" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_860_zyHF8Uv9Sw7i">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	18781000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	27553000	usd
CY2024Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	469000	usd
CY2023Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1100000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	18781000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	27553000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2869000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21753000	usd
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1635000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-9000000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1001000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	3018000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1657000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	4993000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1890000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14728000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1001000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3018000	usd
CY2024Q1	cpss	Gross Balance Of Repossessions In Inventory GrossBalanceOfRepossessionsInInventory	546000	usd
CY2023Q4	cpss	Gross Balance Of Repossessions In Inventory GrossBalanceOfRepossessionsInInventory	597000	usd
CY2024Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-429000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-472000	usd
CY2024Q1	us-gaap	Foreclosed Assets ForeclosedAssets	117000	usd
CY2023Q4	us-gaap	Foreclosed Assets ForeclosedAssets	125000	usd
CY2024Q1	cpss	Final Scheduled Payment Date FinalScheduledPaymentDate	–
CY2024Q1	cpss	Receivables Pledged ReceivablesPledged	2652004000	usd
CY2024Q1	cpss	Securitization Trust Debt Initial Principal SecuritizationTrustDebtInitialPrincipal	5498867000	usd
CY2024Q1	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2292235000	usd
CY2023Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2280021000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	14600000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	14600000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	137700000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	373940000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	301813000	usd
CY2024Q1	cpss	Securitization Of Residual Interests SecuritizationOfResidualInterests	50000000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	50000000	usd
CY2024Q1	cpss	Securitization Of Residual Interests Outstanding SecuritizationOfResidualInterestsOutstanding	50000000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	125000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	2337000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	4662000	usd
CY2024Q1	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	80505000	usd
CY2023Q1	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	74058000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1446000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1342000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	84288000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	80062000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	41968000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	32759000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21143000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20418000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3459000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4974000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24602000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25392000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1700000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1700000	shares
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3500000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30	pure
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4600000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2023Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1100000	usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1240000	usd
CY2021Q3	us-gaap	Trustee Fees TrusteeFees	75000	usd
CY2024Q1	cpss	Probable Legal Contingencies ProbableLegalContingencies	3600000	usd
CY2024Q1	cpss	Maximum Possible Losses For Legal Proceedings And Contingencies MaximumPossibleLossesForLegalProceedingsAndContingencies	5600000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2476617000	usd
CY2024Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	328893000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	352598000	usd
CY2024Q1	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-210935000	usd
CY2023Q1	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-206626000	usd
CY2024Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	54247000	usd
CY2023Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	47472000	usd
CY2024Q1	cpss	Mark To Fair Value MarkToFairValue	5000000	usd
CY2023Q1	cpss	Mark To Fair Value MarkToFairValue	0	usd
CY2024Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2791373000	usd
CY2023Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2575117000	usd
CY2024Q1	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	3001859000	usd
CY2024Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2791373000	usd
CY2023Q4	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	2941915000	usd
CY2024Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2791373000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
CY2024Q1	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.0% - 11.9%
CY2023	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.0% - 11.7%
CY2024Q1	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	10.0% - 22.4%
CY2023	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	10.0% - 21.7%
CY2024Q1	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3001859000	usd
CY2023Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	2941915000	usd
CY2024Q1	cpss	Valuation Allowances And Reserve Adjustments ValuationAllowancesAndReserveAdjustments	429000	usd
CY2024Q1	cpss	Recovery Rate RecoveryRate	0.21	pure
CY2024Q1	cpss	Fair Value And Carrying Amount Of Repossessed Vehicles FairValueAndCarryingAmountOfRepossessedVehicles	117000	usd
CY2023	cpss	Fair Valuation Adjustment Of Repossed Inventory FairValuationAdjustmentOfRepossedInventory	472000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13249000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	137706000	usd
CY2024Q1	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	15034000	usd
CY2024Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	191000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	249522000	usd
CY2024Q1	cpss	Residuals Interest Financing ResidualsInterestFinancing	98968000	usd
CY2024Q1	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	8423000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	2252211000	usd
CY2024Q1	us-gaap	Subordinated Debt SubordinatedDebt	22140000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6174000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	119257000	usd
CY2023Q4	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	20848000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	292000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	234025000	usd
CY2023Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	7928000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	2183331000	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	17188000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-003234-index-headers.html	Edgar Link	pending
0001683168-24-003234-index.html	Edgar Link	pending
0001683168-24-003234.txt	Edgar Link	pending
0001683168-24-003234-xbrl.zip	Edgar Link	pending
cpss-20240331.xsd	Edgar Link	pending
cps_ex3101.htm	Edgar Link	pending
cps_ex3102.htm	Edgar Link	pending
cps_ex3200.htm	Edgar Link	pending
cps_i10q-033124.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
cpss-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpss-20240331_pre.xml	Edgar Link	unprocessable
cps_i10q-033124_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpss-20240331_def.xml	Edgar Link	unprocessable
cpss-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSS
Consumer Portfolio Services Inc Stock $cpss

2024 Q2 Form 10-Q Financial Statement

#000168316824003234 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS Consumer Portfolio Services Inc Stock $cpss

2024 Q2 Form 10-Q Financial Statement

#000168316824003234 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS
Consumer Portfolio Services Inc Stock $cpss